Ngā hua rapu - Shilpi Arora

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

    Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer mā David O. Azorsa, Irma M. Gonzales, Gargi D. Basu, Ashish Choudhary, Shilpi Arora, Kristen Bisanz, Jeffrey Kiefer, Meredith C. Henderson, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes

    Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes mā John P. McGrath, Kaylyn E. Williamson, Srividya Balasubramanian, Shobu Odate, Shilpi Arora, Charlie Hatton, Thomas M. Edwards, Thomas O’Brien, Steven Magnuson, David Stokoe, Danette L. Daniels, Barbara M. Bryant, Patrick Trojer

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    RNAi screening of the kinome with cytarabine in leukemias

    RNAi screening of the kinome with cytarabine in leukemias mā Raoul Tibes, James M. Bogenberger, Leena Chaudhuri, R. Tanner Hagelstrom, Donald Chow, Megan Buechel, Irma M. Gonzales, Tim Demuth, James L. Slack, Ruben A. Mesa, Esteban Braggio, Hongwei Yin, Shilpi Arora, David O. Azorsa

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration

    MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration mā Shilpi Arora, Aarati R. Ranade, Nhan L. Tran, Sara Nasser, Shravan Sridhar, Ronald L. Korn, Julianna T.D. Ross, Harshil Dhruv, Kristen M. Foss, Zita A. Sibenaller, Timothy C. Ryken, Michael B. Gotway, Seungchan Kim, Glen J. Weiss

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of <i>ARID1A</i> Mutant Cancers

    Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of <i>ARID1A</i> Mutant Cancers mā Patricia J. Keller, Elizabeth J. Adams, Rentian Wu, Alexandre Côté, Shilpi Arora, Nico Cantone, Rosana Meyer, Jennifer A. Mertz, Victor Gehling, Jike Cui, Jacob I. Stuckey, Avinash Khanna, Feng Zhao, Zehua Chen, Ziyang Yu, Richard Cummings, Mohammed Taimi, Nehal J. Lakhani, Drew Rasco, Martin Gutierrez, Linda Duska, Michael Devitt, Ronda Rippley, Julian Levell, Jennifer Truong, Jing Wang, Kaiming Sun, Patrick Trojer

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target

    Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target mā Laura A. Marlow, Jaclyn D'Innocenzi, Yilin Zhang, Stephen D. Rohl, Simon Cooper, Thomas Sebo, Clive S. Grant, Bryan McIver, Jan L. Kasperbauer, J. Trad Wadsworth, John D. Casler, Pamela W. Kennedy, W. Edward Highsmith, Orlo H. Clark, Dragana Milosevic, Brian C. Netzel, Kendall W Cradic, Shilpi Arora, Christian Beaudry, Stefan K. Grebe, Marc L. Silverberg, David O. Azorsa, Robert C. Smallridge, John A. Copland

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: